MAPP BIOPHARMACEUTICAL, INC. SBIR Phase II Award, July 2017
A SBIR Phase II contract was awarded to Mapp Biopharmaceutical Inc in July, 2017 for $3,000,000.0 USD from the U.S. Department of Health & Human Services.
Currently, there are no issues on this topic.
Find more entities like MAPP BIOPHARMACEUTICAL, INC. SBIR Phase II Award, July 2017
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.